Although PI3K is downstream of Her‐2 signaling, we saw many differences between mammary tumors arising in transgenic mice overexpressing Her‐2 versus PIK3CA‐H1047R, reflecting differences observed between wild‐type and mutant PI3K. The gene discussed is PIK3CA; the disease is breast cancer.